(HealthDay News) – For children and adolescents with type 1 diabetes, the 90-minute mixed-meal tolerance test (MMTT)-stimulated C-peptide (CP; 90CP) is a highly sensitive and specific measure of area under the curve (AUC) and peak CP and may be used as an alternative to a full MMTT, according to a study published online Oct 30 in Diabetes Care.
Rachel EJ Besser, PhD, from Peninsula Medical School at the University of Exeter in the United Kingdom, and colleagues examined whether 90CP or fasting CP (FCP) can be used as alternatives to a full MMTT. In 421 patients <18 years with type 1 diabetes, CP was measured during 1,334 MMTTs at three, nine, 18, 48, and 72 months of diabetes duration.
The researchers found a correlation for AUC CP of 0.96 for 90CP and 0.84 for FCP. AUC CP ≥23nmol/L/150min was the equivalent cut-off for peak CP ≥0.2nmol/L, with 98% sensitivity and 97% specificity. A 90CP ≥0.2nmol/L correctly classified 96% of patients using AUC or peak CP, while an FCP ≥0.1nmol/L correctly classified 83% and 85% of patients, respectively. Only a small difference was noted between peak and 90CP. Patients with longer duration of diabetes and younger age had an earlier occurring CP peak.
“In conclusion, our study demonstrates that, in children and adolescents with type 1 diabetes, a mixed-meal stimulated 90-min CP is a highly sensitive, specific, and practical alternative measure to peak and AUC CP, with advantages over FCP,” the authors write.